427 related articles for article (PubMed ID: 33180323)
1. Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
Serrao A; Merli M; Lucani B; Aprile F; Fiori L; Gioia S; Breccia M; Riggio O; Chistolini A
Eur J Clin Invest; 2021 Jan; 51(1):e13356. PubMed ID: 33180323
[TBL] [Abstract][Full Text] [Related]
2. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism.
Robertson L; Kesteven P; McCaslin JE
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010957. PubMed ID: 26636644
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
De Gottardi A; Trebicka J; Klinger C; Plessier A; Seijo S; Terziroli B; Magenta L; Semela D; Buscarini E; Langlet P; Görtzen J; Puente A; Müllhaupt B; Navascuès C; Nery F; Deltenre P; Turon F; Engelmann C; Arya R; Caca K; Peck-Radosavljevic M; Leebeek FWG; Valla D; Garcia-Pagan JC;
Liver Int; 2017 May; 37(5):694-699. PubMed ID: 27778440
[TBL] [Abstract][Full Text] [Related]
4. Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study.
Goldhaber SZ; Ageno W; Casella IB; Chee KH; Schellong S; Singer DE; Desch M; Reilly PA; Donado E; Tang W; Voccia I; Schulman S
Am J Med; 2020 Aug; 133(8):936-945. PubMed ID: 32325043
[TBL] [Abstract][Full Text] [Related]
5. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location.
Janczak DT; Mimier MK; McBane RD; Kamath PS; Simmons BS; Bott-Kitslaar DM; Lenz CJ; Vargas ER; Hodge DO; Wysokinski WE
Mayo Clin Proc; 2018 Jan; 93(1):40-47. PubMed ID: 29217335
[TBL] [Abstract][Full Text] [Related]
7. Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study.
Badreldin H
J Thromb Thrombolysis; 2018 Jul; 46(1):16-21. PubMed ID: 29626281
[TBL] [Abstract][Full Text] [Related]
8. Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis.
Cheung YW; Middeldorp S; Prins MH; Pap AF; Lensing AW; Ten Cate-Hoek AJ; Villalta S; Milan M; Beyer-Westendorf J; Verhamme P; Bauersachs RM; Prandoni P;
Thromb Haemost; 2016 Sep; 116(4):733-8. PubMed ID: 27583311
[TBL] [Abstract][Full Text] [Related]
9. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
Beyer-Westendorf J; Ageno W
Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
[TBL] [Abstract][Full Text] [Related]
10. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
Malec K; Góralczyk T; Undas A
Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
[TBL] [Abstract][Full Text] [Related]
11. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.
Ageno W; Riva N; Schulman S; Beyer-Westendorf J; Bang SM; Senzolo M; Grandone E; Pasca S; Di Minno MN; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Oh D; D'Amico E; Becattini C; De Stefano V; Vidili G; Vaccarino A; Nardo B; Di Nisio M; Dentali F
JAMA Intern Med; 2015 Sep; 175(9):1474-80. PubMed ID: 26168152
[TBL] [Abstract][Full Text] [Related]
12. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.
Riva N; Ageno W; Poli D; Testa S; Rupoli S; Santoro R; Lerede T; Piana A; Carpenedo M; Nicolini A; Ferrini PM; Tosetto A; ;
J Thromb Haemost; 2015 Jun; 13(6):1019-27. PubMed ID: 25845412
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations.
Cohen O; Caiano LM; Levy-Mendelovich S
Thromb Res; 2024 Feb; 234():75-85. PubMed ID: 38183815
[TBL] [Abstract][Full Text] [Related]
15. Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy.
Finks SW; Trujillo TC; Dobesh PP
Ann Pharmacother; 2016 Jun; 50(6):486-501. PubMed ID: 26917821
[TBL] [Abstract][Full Text] [Related]
16. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.
Siragusa S; Malato A; Saccullo G; Iorio A; Di Ianni M; Caracciolo C; Coco LL; Raso S; Santoro M; Guarneri FP; Tuttolomondo A; Pinto A; Pepe I; Casuccio A; Abbadessa V; Licata G; Battista Rini G; Mariani G; Di Fede G
Am J Hematol; 2011 Nov; 86(11):914-7. PubMed ID: 21953853
[TBL] [Abstract][Full Text] [Related]
17. Cancer-Associated Splanchnic Vein Thrombosis.
Cohen O; Caiano LM; Tufano A; Ageno W
Semin Thromb Hemost; 2021 Nov; 47(8):931-941. PubMed ID: 34116580
[TBL] [Abstract][Full Text] [Related]
18. Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan.
Nakamura M; Yamada N; Ito M
J Atheroscler Thromb; 2017 Jun; 24(6):560-565. PubMed ID: 28392512
[TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.
Sebastian T; Hakki LO; Spirk D; Baumann FA; Périard D; Banyai M; Spescha RS; Kucher N; Engelberger RP
Thromb Res; 2018 Dec; 172():86-93. PubMed ID: 30391776
[TBL] [Abstract][Full Text] [Related]
20. The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants.
Prandoni P; Ageno W; Ciammaichella M; Mumoli N; Zanatta N; Imberti D; Visonà A; Bucherini E; Di Nisio M; Noventa F;
Intern Emerg Med; 2020 Apr; 15(3):447-452. PubMed ID: 31667697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]